References
Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin 1996; 46: 5–27.
Woolf SH. Current concepts: Screening for prostate cancer with prostate-specific antigen-an examination of the evidence. N Engl J Med1995; 333: 1401–5.
Prorok P. The National Cancer Institute Multi-Screening Trial. Can J Oncol 1994; 4(Suppl): 98–101.
Gohagan JK, Prorok PC, Kramer BS, Cornett JE. Prostate cancer screening in the prostate, lung, colorectal, and ovarian screening trial of the National Cancer Institute. J Urol 1994; 152: 1905–9.
Schroder FH. The European Screening Study for Prostate Cancer. Can J Oncol 1994; 4(Suppl): 102–5.
Gann PH, Hennekens CH, Stampfer MF. A prospective evaluation of plasma prostate-specific antigen for detection of prostate cancer. JAMA 1995; 25: 289–94.
Richie JP, Catalona WJ, Ahmann FR, et al. Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology 1993; 42: 365–74.
Fowler FJ, Barry MJ, Lu-Yao G, et al. Patient-reported complications and follow-up treatment after radical prostatectomy. Urology 1993; 42: 622–9.
Lu-Yao GL, Potosky AL, Albertsen PC, et al. Follow-up prostate cancer treatments after radical prostatectomy: a population based study. JNCI1996; 88: 166–73.
Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 1994; 152: 1910–4.
Stephenson J. Prostate cancer gene hunters track their quarry. [Medical News and Perspectives]. JAMA 1996; 276: 861–2.
Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.N Engl J Med1992; 326: 653–7.
Friedman GD, Hiatt RA, Quesenberry CP Jr, Selby JV. Case-control study of screening for prostatic cancer by digital rectal examinations. Lancet 1991; 337: 1526–9.
Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer1974; 34: 2018–27.
Lang CA, Ransohoff DF. Fecal occult blood screening for colorectal cancer: Is mortality reduced by chance selection for screening colonoscopy? JAMA 1994; 271: 1011–3.
Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995; 109: 1781–90.
Bhattacharya I, Sack E. Screening colonoscopy: the cost of common sense. Lancet 1996; 347: 1744–5.
McNaughton Collins M, Barry MJ. Controversies in prostate cancer screening: Analogies to the early lung cancer screening debate. JAMA 1996; 276: 1976–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McNaughton Collins, M., Fletcher, R.H. Conference report: Research questions concerning prostate cancer screening. Cancer Causes Control 8, 668–671 (1997). https://doi.org/10.1023/A:1018410817024
Issue Date:
DOI: https://doi.org/10.1023/A:1018410817024